Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting
Journal of Biomedicine and Translational Research · 30.04.2026 · 12 (1) · 28-35
DOI: 10.14710/jbtr.v12i1.30107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedicine and Translational Research, online erschienen am 30.04.2026. Verfasst von Irene Astrid Larasati und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Background
The 21-hydroxylase deficiency (21OHD) accounted for the majority of autosomal recessive inherited congenital adrenal hyperplasia (CAH) cases. A genetic test could offer a more thorough diagnostic approach because of the wide range of disease’s severity, but it was challenging in a resource-limited setting.
Objective
To apply a simple and cost-effective rapid molecular screening for detecting the most common CYP21A2 variants causing salt-wasting (SW) CAH.
Methods
DNA extraction was conducted using a salting out method from a venous blood sample taken from 49 CAH patients without prior genetic testing. A PCR-RFLP approach was utilized using primer sets specifically designed to anneal to the CYP21A2. Specific restriction enzymes were selected to cleave the DNA sequence, differentiating the wild and mutant type, i.e, the p.Arg357Trp, p.Gln318Ter, IVS2-13A/C>G, and exon 6 cluster. Samples positive for those mutation types detected from DNA sequencing, used as positive controls.
Results
The most common variant was IVS2-13A/C>G, detected in 26 out of 27 patients. Only 6.1% of 49 patients were found to have the p.Gln318Ter variant. Both the p.Arg357Trp and exon 6 cluster carried inconclusive results. All patients detected with the IVS2-13A/C>G and p.Gln318Ter had a phenotype of SW CAH.
Conclusion
The PCR-RFLP was an advantageous method for identifying CYP21A2 variants in a low-resource setting. Nevertheless, the use of multiplex ligation-probe dependent amplification (MLPA) and Sanger sequencing offered a comprehensive analysis to discover novel variants that could help with patients' diagnosis and treatment.
Zitieren
APA
Larasati, I. A., Maharani, N., Utari, A., & Winarni, T. I. (2026). Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting. Journal of Biomedicine and Translational Research, 12(1), 28-35. https://doi.org/10.14710/jbtr.v12i1.30107
Vancouver
Larasati IA, Maharani N, Utari A, Winarni TI. Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting. Journal of Biomedicine and Translational Research. 2026;12(1):28-35. doi:10.14710/jbtr.v12i1.30107
BibTeX
@article{Larasati2026,
author = {Larasati, Irene Astrid and Maharani, Nani and Utari, Agustini and Winarni, Tri Indah},
title = {Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting},
journal = {Journal of Biomedicine and Translational Research},
year = {2026},
volume = {12},
number = {1},
pages = {28--35},
doi = {10.14710/jbtr.v12i1.30107}
}
EUVIMED